Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.

Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.

OBJECTIVE: Previous studies of surgical treatment for acromegaly have used varied criteria for 'cure', but elevated GH levels are considered to be associated with continuing disease activity. We wished to analyse the results of transsphenoidal pituitary surgery for acromegaly and assess th...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Sheaves, R, Jenkins, P, Blackburn, P, Huneidi, A, Afshar, F, Medbak, S, Grossman, A, Besser, G, Wass, J
Formato:	Journal article
Idioma:	English
Publicado em:	1996

Registos relacionados

Criteria for cure of acromegaly: a consensus statement.
Por: Giustina, A, et al.
Publicado em: (2000)

The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours.
Por: Harris, P, et al.
Publicado em: (1989)

Acromegaly, colonic polyps and carcinoma.
Por: Jenkins, P, et al.
Publicado em: (1997)

Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Por: Storr, H, et al.
Publicado em: (2005)

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
Por: Grossman, A, et al.
Publicado em: (1985)

Depot-bromocriptine treatment for prolactinomas and acromegaly.
Por: Grossman, A, et al.
Publicado em: (1986)

Quality of Life in Patients with Acromegaly before and after Transsphenoidal Surgical Resection
Por: Jing Gu, et al.
Publicado em: (2020-01-01)

The pathology of median neuropathy in acromegaly.
Por: Jenkins, P, et al.
Publicado em: (2000)

Uterine leiomyomata in women with acromegaly
Por: Kaltsas, G, et al.
Publicado em: (2000)

Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease.
Por: Storr, H, et al.
Publicado em: (2011)

Menstrual irregularity in women with acromegaly.
Por: Kaltsas, G, et al.
Publicado em: (1999)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
Por: Kaltsas, G, et al.
Publicado em: (2001)

Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
Por: Trainer, P, et al.
Publicado em: (1993)

Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly.
Por: Besser, G, et al.
Publicado em: (1983)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
Por: Ur, E, et al.
Publicado em: (1992)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
Por: Jenkins, P, et al.
Publicado em: (2000)

Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
Por: Ahmed, S, et al.
Publicado em: (1999)

Acromegaly: Beyond surgery.
Por: Thanabalasingham, G, et al.
Publicado em: (2013)

New treatments for acromegaly.
Por: Wass, J, et al.
Publicado em: (1998)

Guidelines for acromegaly management.
Por: Melmed, S, et al.
Publicado em: (2002)

Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly.
Por: Jenkins, P, et al.
Publicado em: (2000)

Acromegaly: Beyond surgery
Por: Gaya Thanabalasingham, et al.
Publicado em: (2013-01-01)

Impact of strict IGF1 control on quality-of-life scores in patients with acromegaly
Por: Chaitanya Gandhi, et al.
Publicado em: (2025-01-01)

Outcome of endoscopic transsphenoidal surgery for acromegaly: Comparison of using and not using the floor standing pneumatic powered endoscope-holder system
Por: Masahiko Tosaka, et al.
Publicado em: (2024-08-01)

Long-term effects of radiotherapy for acromegaly.
Por: Wass, J
Publicado em: (1996)

Insulin-like growth factor-I (IGF-I) as a risk factor for colonic adenomas in patients with acromegaly.
Por: Jenkins, P, et al.
Publicado em: (1998)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
Por: Wass, J
Publicado em: (1997)

Radiotherapy in acromegaly: a protagonists viewpoint.
Por: Wass, J
Publicado em: (2003)

Acromegaly: Treatment with somatostatin analogs
Por: Karavitaki, N, et al.
Publicado em: (2005)

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
Por: Karavitaki, N, et al.
Publicado em: (2008)

Transsphenoidal pituitary surgery in the elderly is safe and effective.
Por: Pereira, E, et al.
Publicado em: (2014)

Investigation protocol: acromegaly and its investigation.
Por: Duncan, E, et al.
Publicado em: (1999)

Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
Por: Ngo Manh Hung, et al.
Publicado em: (2020-12-01)

Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
Por: Wass, J
Publicado em: (2003)

Surgical Outcome of Endoscopic Transsphenoidal Surgery for Giant Pituitary Adenoma
Por: Abdulrahman Alrefaey Aldengawy, et al.
Publicado em: (2021-04-01)

Endoscopic endonasal approach for acromegaly: surgical outcomes using 2018 consensus criteria for remission
Por: Rodrigo Alves de Carvalho Cavalcante, et al.
Publicado em: (2023-07-01)

Colonic Cancer and Acromegaly
Por: Dorota Dworakowska, et al.
Publicado em: (2019-06-01)

Pegvisomant: a new treatment modality for acromegaly.
Por: Karavitaki, N, et al.
Publicado em: (2004)

Conventional Pituitary Irradiation Is Effective in Lowering Serum Growth Hormone and Insulin-Like Growth Factor-I in Patients with Acromegaly
Por: Jenkins, P, et al.
Publicado em: (2006)

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
Por: Turner, H, et al.
Publicado em: (1999)